Evidence map›Paper›PMID 36439256›Full record

ReviewFrontiers in physiology2022

E3 ubiquitin ligases in the acute leukemic signaling pathways.

Qianru Zhan, Heyang Zhang, Boquan Wu, Naijin Zhang, Lijun Zhang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. The roles of ubiquitination in AML.Annals of hematology · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qianru ZhanDepartment of Hematology, The First Hospital of China Medical University, Shenyang, China.
Heyang ZhangDepartment of Hematology, The First Hospital of China Medical University, Shenyang, China.
Boquan WuDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Naijin ZhangDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Lijun ZhangDepartment of Hematology, The First Hospital of China Medical University, Shenyang, China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute leukemia is a common hematologic tumor with highly genetic heterogeneity, and many factors are involved in the pathogenesis and drug-resistance mechanism. Emerging evidence proves that E3 ubiquitin ligases participate in the acute leukemic signaling pathways

Indexed as

acute leukemiaE3 ubiquitin ligasesJAK2NF-κBNotchPI3K/AKTWnt/β-catenin

Identifiers

PMID36439256
PMCPMC9691902
OpenAlexW4308801659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.